ERNA Stock Analysis: Buy, Sell, or Hold?
ERNA - Ernexa Therapeutics Inc. Common Stock
$0.31
0.01 (2.89%)
▲
5d:
+4.64%
30d:
-75.27%
90d:
-76.05%
BUY
HIGH Confidence
Analysis Updated: Mar 4, 2026 12:00 AM ET
Earnings: Mar 11, 2026
5d
Get Alerted When ERNA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called ERNA this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ERNA shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: ERNA shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: ERNA is currently trading at $0.31, which is considered slightly low relative to its 30-day fair value range of $0.27 to $1.11.
Technical Outlook: Technically, ERNA is in a strong downtrend. Immediate support is located at $0.27, while resistance sits at $0.38.
Market Sentiment: ERNA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $3.00 (+878.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ERNA is in a strong downtrend. Immediate support is located at $0.27, while resistance sits at $0.38.
Market Sentiment: ERNA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $3.00 (+878.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$0.27 -
$1.11
Company Quality Score
51/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
89.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: Trading 878.5% below Wall St target ($3.00)
Fair Price Analysis
30-Day Fair Range
$0.27 -
$1.11
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.27
Resistance Level
$0.38
Current Trend
Strong Downtrend
Technical data as of
Mar 4, 2026
Fundamental Context
Wall Street Target
$3.00
(+878.5%)
Revenue Growth (YoY)
-94.1%
Share & Embed Analysis
Last updated: March 05, 2026 4:04 AM ET
Data refreshes hourly during market hours. Next update: 5:04 AM
Data refreshes hourly during market hours. Next update: 5:04 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ERNA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 44 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$57 | 60 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$216 | 51 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$283 | 64 BUY |
|
VERA
Vera Therapeutics Inc |
STRONG BUY
14 analysts |
$75 | 54 HOLD |
